Skip to the page

Data / Drug companies / Verapamil hydrochloride

Verapamil hydrochloride: 46 companies and 132 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Verapamil hydrochloride is listed in the FDA National Drug Code Directory by 46 companies, with 132 products in commercial distribution. 121 of the products (91.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection, solution; tablet, film coated, extended release, and the newest product started marketing on May 21, 2026.

The request: Get every company that lists verapamil hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
46
Products
132
Generic (ANDA) products
121 (91.7%)
Application numbers
26
Routes
Oral, Intravenous
openFDA record search
api.fda.gov

Companies that list verapamil hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Medical Purchasing Solutions, LLC7injection; injection, solutionGeneric drugs (ANDA)June 16, 2022
Wilshire Pharmaceuticals, Inc.7capsule, delayed release; capsule, extended releaseAuthorized generics (NDA)November 26, 2024
Bryant Ranch Prepack6tablet; tablet, film coatedGeneric drugs (ANDA)January 2, 2023
Northwind Health Company, LLC6tablet; tablet, film coated, extended releaseGeneric drugs (ANDA)January 31, 2023
NuCare Pharmaceuticals,Inc.6tablet; tablet, film coated, extended releaseGeneric drugs (ANDA)May 15, 2019
A-S Medication Solutions5tablet, film coated, extended release; tabletGeneric drugs (ANDA)January 2, 2023
HF Acquisition Co LLC, DBA HealthFirst5injection, solutionGeneric drugs (ANDA)May 20, 2022
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.5tablet; injectionGeneric drugs (ANDA)January 15, 2025
Zydus Lifesciences Limited5tablet; injection, solutionGeneric drugs (ANDA)May 21, 2026
Chartwell RX, LLC4tablet; capsule, extended releaseGeneric drugs (ANDA)July 20, 2018
Preferred Pharmaceuticals Inc.4tablet, film coated, extended release; tabletGeneric drugs (ANDA)June 11, 2024
Remedyrepack Inc.4tablet, film coated, extended release; injection, solutionGeneric drugs (ANDA)November 1, 2025
Actavis Pharma, Inc.3tablet, film coatedGeneric drugs (ANDA)June 29, 1993
AvKARE3tabletGeneric drugs (ANDA)April 13, 2020
Cadila Pharmaceuticals Limited3tablet, extended releaseGeneric drugs (ANDA)May 27, 2017
Glenmark Pharmaceuticals Inc., USA3tablet, film coated, extended releaseGeneric drugs (ANDA)August 5, 2011
Golden State Medical Supply, Inc.3tabletGeneric drugs (ANDA)October 14, 2015
Hospira, Inc.3injection, solutionGeneric drugs (ANDA)June 20, 2018
Mylan Pharmaceuticals Inc.3capsule, extended releaseGeneric drugs (ANDA)May 20, 1999
Nivagen Pharmaceuticals, Inc.3tablet, film coated, extended releaseGeneric drugs (ANDA)January 2, 2023
Proficient Rx LP3tablet, film coated; tablet, film coated, extended releaseGeneric drugs (ANDA)May 15, 2019
Somerset Therapeutics, LLC3injection, solutionGeneric drugs (ANDA)June 18, 2018
Zydus Pharmaceuticals USA Inc.3injection, solutionGeneric drugs (ANDA)October 17, 2023
Zydus Pharmaceuticals USA Inc.3tabletGeneric drugs (ANDA)May 21, 2026
Amneal Pharmaceuticals LLC2injection, solutionGeneric drugs (ANDA)July 17, 2018
Aphena Pharma Solutions - Tennessee, LLC2tablet, film coated, extended release; tabletGeneric drugs (ANDA)May 15, 2019
Armas Pharmaceuticals Inc.2injectionGeneric drugs (ANDA)January 1, 2020
Baxter Healthcare Corporation2injection, solutionGeneric drugs (ANDA)March 25, 2020
Caplin Steriles Limited2injection, solutionGeneric drugs (ANDA)January 16, 2025
Eugia US LLC2injection, solutionGeneric drugs (ANDA)July 6, 2020
Exela Pharma Sciences, LLC2injectionNew drug applications (NDA)February 1, 2017
Gland Pharma Limited2injectionGeneric drugs (ANDA)October 15, 2020
Henry Schein, Inc.2injection, solutionGeneric drugs (ANDA)January 11, 2022
Lifestar Pharma LLC2injection, solutionGeneric drugs (ANDA)June 16, 2022
Bryant Ranch Prepack1tabletGeneric drugs (ANDA)January 7, 2011
Bryant Ranch Prepack1tablet, film coatedGeneric drugs (ANDA)October 1, 1986
Fresenius Kabi USA, LLC1injectionGeneric drugs (ANDA)November 25, 2024
Micro Labs Limited1injectionGeneric drugs (ANDA)March 4, 2019
Mylan Institutional Inc.1capsule, extended releaseGeneric drugs (ANDA)October 1, 1999
NuCare Pharmaceuticals, Inc.1tablet, film coated, extended releaseGeneric drugs (ANDA)September 17, 2009
PD-Rx Pharmaceuticals, Inc.1tablet, film coated, extended releaseGeneric drugs (ANDA)September 17, 2009
PD-Rx Pharmaceuticals, Inc.1tablet, film coated, extended releaseGeneric drugs (ANDA)August 5, 2011
ProPharma Distribution1injection, solutionGeneric drugs (ANDA)June 16, 2022
Proficient Rx LP1tablet, film coated, extended releaseGeneric drugs (ANDA)August 5, 2011
Safecor Health, LLC1capsule, extended releaseGeneric drugs (ANDA)May 5, 2026
Sagent Pharmaceuticals1injection, solutionGeneric drugs (ANDA)March 15, 2021

Dosage forms

Dosage formProductsShare
Tablet3828.8%
Injection, solution3425.8%
Tablet, film coated, extended release2216.7%
Injection1410.6%
Capsule, extended release96.8%
Tablet, film coated86.1%
Capsule, delayed release43%
Tablet, extended release32.3%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)12191.7%
Authorized generics (NDA)86.1%
New drug applications (NDA)32.3%

Pharmacologic classes

ClassProducts
Calcium Channel Blocker132

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.